<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1527">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05411822</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 21-0400</org_study_id>
    <nct_id>NCT05411822</nct_id>
  </id_info>
  <brief_title>Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment</brief_title>
  <official_title>Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment and Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to investigate the relationship between light, the&#xD;
      thickness of the pigment at the back of your eye, melatonin levels, and memory. The study&#xD;
      will investigate whether changing light distribution pattern from &quot;on-axis&quot;' (i.e., directed&#xD;
      along the eye's visual axis to the fovea) to &quot;off-axis&quot; (i.e., directed on the periphery of&#xD;
      the eye's visual axis) impact melatonin suppression in 24 mild cognitive impairment&#xD;
      participants and 24 healthy, age-matched controls.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible enrolled subjects will be exposed to 4 different lighting conditions in addition to&#xD;
      one dark control condition. There will be 5 study session and each one will last for 90&#xD;
      minutes and will be separated by one week. Subjects will collect 3 saliva samples, each one&#xD;
      30 minutes apart for melatonin levels during each study session.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 28, 2021</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in melatonin levels</measure>
    <time_frame>one sample will be collected every 30 minutes during each 90 minute study session up to 5 weeks</time_frame>
    <description>Saliva samples will be collected for melatonin analysis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>Lighting Intervention Blue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blue light (λmax = 451 nm) on and off axis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lighting Intervention Green</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Green light (λmax = 522 nm) on and off axis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lighting Intervention Blue light</intervention_name>
    <description>Custom made lighting fixture that will deliver the blue lighting intervention</description>
    <arm_group_label>Lighting Intervention Blue</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lighting Intervention Green light</intervention_name>
    <description>Custom made lighting fixture that will deliver the green lighting intervention</description>
    <arm_group_label>Lighting Intervention Green</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  mild cognitive impairment&#xD;
&#xD;
          -  age matched healthy control&#xD;
&#xD;
          -  macular pigment density either &lt; 0.3 or &gt; 0.5&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  extensive brain vascular disease&#xD;
&#xD;
          -  Parkinson's disease&#xD;
&#xD;
          -  bipolar disorder&#xD;
&#xD;
          -  seasonal depression&#xD;
&#xD;
          -  diabetes&#xD;
&#xD;
          -  high blood pressure&#xD;
&#xD;
          -  obstructing cataracts&#xD;
&#xD;
          -  macular degeneration&#xD;
&#xD;
          -  diabetic retinopathy&#xD;
&#xD;
          -  use of melatonin supplements&#xD;
&#xD;
          -  use of beta blockers&#xD;
&#xD;
          -  use of sleep medications&#xD;
&#xD;
          -  use of antidepressant medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariana Figueiro, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Plitnick, BSN</last_name>
    <phone>518 366-9306</phone>
    <email>barbara.plitnick@mountsinai.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Light and Health Research Center at Mount Sinai</name>
      <address>
        <city>Menands</city>
        <state>New York</state>
        <zip>12204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Plitnick, BSN</last_name>
      <phone>518-366-9306</phone>
      <email>barbara.plitnick@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Mariana Figueiro, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2022</verification_date>
  <study_first_submitted>June 2, 2022</study_first_submitted>
  <study_first_submitted_qc>June 6, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2022</study_first_posted>
  <last_update_submitted>June 6, 2022</last_update_submitted>
  <last_update_submitted_qc>June 6, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Mariana Figueiro</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

